CARDIOVASCULAR INFORMATION SYSTEM MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Rising prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases worldwide is posing a serious public health challenge and is a key factor driving the growth of the global cardiovascular information system market. Cardiovascular diseases are the leading cause of deaths globally, accounting for over 17.9 million lives lost each year according to the World Health Organization. The occurrences of conditions like coronary heart disease, stroke, heart attack, and heart failure are steadily increasing. For instance, as per the American Heart Association's Heart Disease and Stroke Statistics report in 2022, coronary heart disease causes around 366,800 deaths in the U.S. each year making it one of the most common causes of mortality. Cardiovascular information systems are becoming increasingly vital for healthcare institutions to better manage these complex conditions and improve patient outcomes. They help in the seamless collection, storage and integration of cardiovascular patient data from various diagnostic sources like ECGs, Holter monitors, echocardiograms, and other cardiac tests. This centralized clinical data repository enables improved clinical decision making, streamlined workflow efficiency, and inter-departmental communication. For instance, according to  American Heart Association, Inc., on June 4, 2024, by 2050, it is projected that over 184 million people in the U.S., which exceeds 61% of the population, will suffer from some form of cardiovascular disease (CVD). This significant increase is attributed to demographic shifts, particularly an older and more diverse population, coupled with rising risk factors like high blood pressure and obesity. According to projections from the American Heart Association, the total costs related to cardiovascular conditions are expected to triple, reaching a staggering US$ 1.8 trillion by 2050. These costs encompass both direct medical expenses and indirect costs related to lost productivity and other economic impacts. These projections were highlighted in recent presidential advisories from the American Heart Association, underscoring the urgent need for enhanced preventive measures and interventions to mitigate the growing burden of cardiovascular disease in the coming decades.